Recently, we applied sensitive and high-throughput mutation detection methods in a pilot study of 205 well-characterized sporadic ccRCC cases to comprehensively evaluate tumor DNA for VHL sequence alterations and promoter methylation, and to identify associations between the prevalence, type, and location of VHL alterations with etiologic and clinical factors [6]. Here, VHL is linked to neoplasm.